Ilsung Is Co., Ltd. (KRX:003120)
22,400
-100 (-0.44%)
Dec 18, 2025, 10:25 AM KST
Ilsung Is Market Cap
Ilsung Is has a market cap or net worth of 156.8 billion as of December 17, 2025. Its market cap has increased by 41.78% in one year.
Market Cap
156.80B
Enterprise Value
-65.66B
Revenue
66.51B
Ranking
n/a
PE Ratio
66.03
Stock Price
22,400.00
Market Cap Chart
Since May 22, 1998, Ilsung Is's market cap has increased from 17.63B to 156.80B, an increase of 789.64%. That is a compound annual growth rate of 8.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 156.80B | 45.16% |
| Dec 30, 2024 | 108.02B | -34.46% |
| Dec 28, 2023 | 164.82B | 31.69% |
| Dec 29, 2022 | 125.15B | 26.20% |
| Dec 30, 2021 | 99.17B | -10.76% |
| Dec 30, 2020 | 111.13B | 0.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.01T |
| Celltrion | 40.48T |
| ALTEOGEN | 22.52T |
| SK Biopharmaceuticals | 10.26T |
| ABL Bio | 10.04T |
| Yuhan | 8.53T |
| LigaChem Biosciences | 6.14T |
| HLB Co., Ltd. | 6.11T |